Sutro Biopharma Inc
NASDAQ:STRO
| Market Cap (Intraday) | 845.36M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $18.62 |
| 50-Day MA | $19.74 |
| 200-Day MA | $18.83 |
Sutro Biopharma Inc Stock, NASDAQ:STRO
310 Utah Avenue, Suite 150, South San Francisco, California 94080
Phone: +1.650.392.8412
Number of Employees: 191
Description
Sutro Biopharma Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.